Claims for Patent: 8,309,077

Summary for Patent: 8,309,077

Title:	Stabilized bacteriophage formulations
Abstract:	Stabilized bacteriophage compositions, and methods for preparing stabilized bacteriophage compositions are provided. The method for producing an antibacterial composition involves adsorbing an aqueous solution of one or more bacteriophages, or one or more phage components, onto a matrix to produce a composition, and drying the composition to produce the antibacterial composition. An antibacterial composition comprising one or more strain of bacteriophage, or one or more phage component, adsorbed onto a matrix is also provided. The antibacterial composition, or the antibacterial composition embedded in a solid support, may be used within a cream, lotion or gel, be admixed with a pharmaceutical carrier and administered topically, orally, nasally, used as a powdered inhalant, or the antibacterial composition or encapsulated antibacterial composition, may be added to a feed for animal, aquatic or avian uses.
Inventor(s):	Murthy; Kishore (Ottawa, CA), Engelhardt; Rainer (Ottawa, CA)
Assignee:	CHR. Hansen A/S (Horsholm, DK)
Application Number:	11/666,709
Patent Claims:	1. An antibacterial composition consisting essentially of one or more than one bacteriophage adsorbed onto a dry matrix of milk powder, wherein when the composition is stored at room temperature for up to 131 days, all bacteriophage remain viable. 2. A composition comprising the antibacterial composition of claim 1 and a pharmaceutically acceptable carrier. 3. A kit comprising a sterile vial comprising the composition of claim 2 and a vial of sterile water for dissolving the composition. 4. A composition comprising an animal feed admixed with the antibacterial composition of claim 1. 5. The composition of claim 4, wherein the animal feed is selected from the group consisting of a human food, bird feed, a fish feed, a porcine feed, a livestock feed, a poultry feed, a domestic animal feed, and a food for aquaculture. 6. The antibacterial composition of claim 1, wherein the composition is formulated within a tablet. 7. The antibacterial composition of claim 6, wherein the tablet further comprises components that permit controlled release of the one or more than one bacteriophage. 8. The antibacterial composition of claim 1, wherein the antibacterial composition is embedded in a solid support. 9. The antibacterial composition of claim 8, wherein the solid support is selected from the group consisting of a microbead, cellulose-based material, carbohydrate-based material, shellac, methacrylates, sugar, mannitol, sorbitol, soya protein, whey protein, algal protein, single cell protein, casein, gelatin, and milk powder. 10. The antibacterial composition according to claim 1, wherein the antibacterial composition is coated with a substance that increases the resistance of the one or more than one bacteriophage to the physico-chemical stresses of the environment of a fermenting animal feed or the digestive system of an animal. 11. The antibacterial composition according to claim 10, wherein the substance is a polymer for controlled release of the one or more than one bacteriophage. 12. The antibacterial composition according to claim 11, wherein the polymer is a methacrylate-based polymer.

Details for Patent 8,309,077

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2024-11-02